HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW
HeartSciences Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.07+0.05 (+1.66%)
Close on Oct 19, 2026
- Market cap
- $11.26M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
HeartSciences statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Finance Services companies for comparison
Valuation
| Measure | HeartSciences | Industry median |
|---|---|---|
| Market Cap | $14.74M | $196.46M |
| Enterprise Value | $14.71M | $149.54M |
| PS Ratio | 3261.02 | 2.60 |
Enterprise value
| Measure | HeartSciences | Industry median |
|---|---|---|
| EV / Sales | 3254.40 | 2.38 |
Income (trailing twelve months)
| Measure | HeartSciences | Industry median |
|---|---|---|
| Revenue | $4.52K | $66.09M |
| Gross Profit | $2.75K | $1.84M |
| Operating Income | -$9.48M | -$13.30M |
| Net Income | -$10.26M | -$4.73M |
| EBITDA | -$9.48M | -$9.63M |
| EPS (Diluted) | -$3.22 | -$0.01 |
Margins
| Measure | HeartSciences | Industry median |
|---|---|---|
| Gross Margin | 60.9% | 41.7% |
| Operating Margin | -209733.0% | -119.4% |
| Profit Margin | -227024.0% | -19.9% |
| EBITDA Margin | -209733.0% | -66.1% |
Returns
| Measure | HeartSciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -1851.9% | -22.3% |
| Return on Assets (ROA) | -201.7% | -11.1% |
Growth
| Measure | HeartSciences | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -5.70% | 5.87% |
Balance sheet
| Measure | HeartSciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $29.91K | $20.41M |
| Total Debt | $0 | $52.25M |
| Net Cash (Debt) | $29.91K | $7.08M |
| Net Cash Per Share | $0.01 | $0.22 |
| Equity (Book Value) | -$2.03M | $200.96M |
| Book Value Per Share | -$0.42 | $3.89 |
| Tangible Book Value | -$3.70M | $127.80M |
| Working Capital | -$4.82M | $8.91M |
Financial position
| Measure | HeartSciences | Industry median |
|---|---|---|
| Current Ratio | 0.14 | 1.45 |
| Quick Ratio | 0.01 | 0.54 |
| Interest Coverage | -11.78 | -7.69 |
Cash flow (trailing twelve months)
| Measure | HeartSciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.79M | -$5.82M |
Efficiency
| Measure | HeartSciences | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.17 |
| Inventory Turnover | 0.00 | 6.30 |
Dividends and yields
| Measure | HeartSciences | Industry median |
|---|---|---|
| Earnings Yield | -69.6% | -11.5% |
| Dividend Yield | 0.00% | 2.22% |
| Shareholder Yield | 0.00% | 0.15% |
| Dividend Per Share | $0.00 | $1.15 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | HeartSciences | Industry median |
|---|---|---|
| Shares Outstanding | 4,800,170 | 55,074,600 |
| Shares Change (YoY) | 198.1% | 12.9% |
| Shares Change (QoQ) | 22.5% | 0.22% |
| Float | 3,876,780 | 41,965,050 |
| Shares Held by Insiders | 19.2% | 18.6% |
| Shares Held by Institutions | 12.8% | 34.2% |
Scores
| Measure | HeartSciences | Industry median |
|---|---|---|
| Altman Z-Score | -41.52 | 0.30 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from HeartSciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.